Expression Analysis of Three MiRNAs, MiR-26a, MiR-29b and MiR-519d, in Relation to MMP-2 Expression Level in Non-small Cell Lung Cancer Patients: a Pilot Study

Overview

Journal Med Oncol

Publisher Springer

Specialty Oncology

Date 2016 Jul 23

PMID 27447710

Citations 9

Authors

D Pastuszak-Lewandoska

J Kordiak

K H Czarnecka

M Migdalska-Sek

E Nawrot

D Domanska-Senderowska

J M Kiszalkiewicz

A Antczak

P Gorski

E Brzezianska-Lasota

Affiliations

Soon will be listed here.

Abstract

Lung cancer is the most common cause of death in men and second only to breast cancer in women. MicroRNAs (miRNAs) are involved in tumorigenesis and function as oncogenes or tumor suppressor genes. Among other genes, miRNAs regulate matrix metalloproteinases (MMPs), the proteolytic enzymes playing a significant role in the degradation of extracellular matrix, enhancing tumor invasion and metastasis. The aim of the study was to evaluate the expression levels of selected miRNAs: miR-26a, miR-29b and miR-519d, and their target gene, matrix metalloproteinase-2 (MMP-2) in patients with non-small cell lung cancer (NSCLC). The results were correlated with tumor staging, NSCLC histopathological subtypes and patients' demographical features to assess the possible diagnostic/prognostic value of the studied miRNAs and MMP-2. Total RNA was isolated from 38 NSCLC tissue samples, and the expression analysis was performed using TaqMan(®) probes in qPCR assay. The results indicated underexpression of selected miRNAs and overexpression of MMP-2. The decrease in miRNA-29b expression was statistically significant and differentiated NSCLC histopathological subtypes. Additionally, statistically significant negative correlation was found between MMP-2 expression and its regulatory miR-26a. There are very few studies reporting miRNA-MMPs analysis on mRNA level in lung cancer, and no similar reports are available from Polish population. The results of our pilot study indicated the diagnostic potential of miR-29b and MMP-2, an inverse association between miR-26a and MMP-2, and proved the role of MMP-2 and the studied miRNAs in lung carcinogenesis. Further studies are needed to verify their potential usefulness for the treatment of lung cancer.

Citing Articles

The multifaceted roles of matrix metalloproteinases in lung cancer.

Wei C Front Oncol. 2023; 13:1195426.

PMID: 37766868 PMC: 10520958. DOI: 10.3389/fonc.2023.1195426.

Biological and Genetic Mechanisms of COPD, Its Diagnosis, Treatment, and Relationship with Lung Cancer.

Czarnecka-Chrebelska K, Mukherjee D, Maryanchik S, Rudzinska-Radecka M Biomedicines. 2023; 11(2).

PMID: 36830984 PMC: 9953173. DOI: 10.3390/biomedicines11020448.

Circulating miRNA-29b and Sclerostin Levels Correlate with Coronary Artery Calcification and Cardiovascular Events in Maintenance Hemodialysis Patients.

He J, Pan M, Xu M, Chen R Cardiol Res Pract. 2022; 2021:9208634.

PMID: 34976409 PMC: 8718313. DOI: 10.1155/2021/9208634.

Serum Extracellular Vesicle-Derived miRNAs in Patients with Non-Small Cell Lung Cancer-Search for Non-Invasive Diagnostic Biomarkers.

Kryczka J, Migdalska-Sek M, Kordiak J, Kiszalkiewicz J, Pastuszak-Lewandoska D, Antczak A Diagnostics (Basel). 2021; 11(3).

PMID: 33802346 PMC: 7998231. DOI: 10.3390/diagnostics11030425.

MicroRNA-26a Protects the Heart Against Hypertension-Induced Myocardial Fibrosis.

Zhang W, Wang Q, Feng Y, Chen X, Yang L, Xu M J Am Heart Assoc. 2020; 9(18):e017970.

PMID: 32865120 PMC: 7726969. DOI: 10.1161/JAHA.120.017970.

References

Fang J, Zhou H, Zeng C, Yang J, Liu Y, Huang X . MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression. Hepatology. 2011; 54(5):1729-40. DOI: 10.1002/hep.24577. View

Lin H, Chiang C, Hung W . STAT3 upregulates miR-92a to inhibit RECK expression and to promote invasiveness of lung cancer cells. Br J Cancer. 2013; 109(3):731-8. PMC: 3738132. DOI: 10.1038/bjc.2013.349. View

Wang H, Zhu Y, Zhao M, Wu C, Zhang P, Tang L . miRNA-29c suppresses lung cancer cell adhesion to extracellular matrix and metastasis by targeting integrin β1 and matrix metalloproteinase2 (MMP2). PLoS One. 2013; 8(8):e70192. PMC: 3735565. DOI: 10.1371/journal.pone.0070192. View

Zhu W, He J, Chen D, Zhang B, Xu L, Ma H . Expression of miR-29c, miR-93, and miR-429 as potential biomarkers for detection of early stage non-small lung cancer. PLoS One. 2014; 9(2):e87780. PMC: 3921142. DOI: 10.1371/journal.pone.0087780. View

Rutnam Z, Wight T, Yang B . miRNAs regulate expression and function of extracellular matrix molecules. Matrix Biol. 2012; 32(2):74-85. PMC: 4106267. DOI: 10.1016/j.matbio.2012.11.003. View

Gouyer V, Conti M, Devos P, Zerimech F, Copin M, Creme E . Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent. Cancer. 2005; 103(8):1676-84. DOI: 10.1002/cncr.20965. View

Zheng D, Haddadin S, Wang Y, Gu L, Perry M, Freter C . Plasma microRNAs as novel biomarkers for early detection of lung cancer. Int J Clin Exp Pathol. 2011; 4(6):575-86. PMC: 3160609. View

Jemal A, Bray F, Center M, Ferlay J, Ward E, Forman D . Global cancer statistics. CA Cancer J Clin. 2011; 61(2):69-90. DOI: 10.3322/caac.20107. View

Ulivi P, Foschi G, Mengozzi M, Scarpi E, Silvestrini R, Amadori D . Peripheral blood miR-328 expression as a potential biomarker for the early diagnosis of NSCLC. Int J Mol Sci. 2013; 14(5):10332-42. PMC: 3676841. DOI: 10.3390/ijms140510332. View

10.

Wang H, Guan X, Tu Y, Zheng S, Long J, Li S . MicroRNA-29b attenuates non-small cell lung cancer metastasis by targeting matrix metalloproteinase 2 and PTEN. J Exp Clin Cancer Res. 2015; 34:59. PMC: 4469413. DOI: 10.1186/s13046-015-0169-y. View

11.

Kesanakurti D, Maddirela D, Chittivelu S, Rao J, Chetty C . Suppression of tumor cell invasiveness and in vivo tumor growth by microRNA-874 in non-small cell lung cancer. Biochem Biophys Res Commun. 2013; 434(3):627-33. DOI: 10.1016/j.bbrc.2013.03.132. View

12.

Visse R, Nagase H . Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res. 2003; 92(8):827-39. DOI: 10.1161/01.RES.0000070112.80711.3D. View

13.

Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K . Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008; 18(10):997-1006. DOI: 10.1038/cr.2008.282. View

14.

Sounni N, Noel A . Membrane type-matrix metalloproteinases and tumor progression. Biochimie. 2005; 87(3-4):329-42. DOI: 10.1016/j.biochi.2004.07.012. View

15.

Leinonen T, Pirinen R, Bohm J, Johansson R, Kosma V . Increased expression of matrix metalloproteinase-2 (MMP-2) predicts tumour recurrence and unfavourable outcome in non-small cell lung cancer. Histol Histopathol. 2008; 23(6):693-700. DOI: 10.14670/HH-23.693. View

16.

Zeng X, Zhang S, Zheng J, Yuan H, Wang Y . Altered miR-143 and miR-150 expressions in peripheral blood mononuclear cells for diagnosis of non-small cell lung cancer. Chin Med J (Engl). 2013; 126(23):4510-6. View

17.

Roth C, Stuckrath I, Pantel K, Izbicki J, Tachezy M, Schwarzenbach H . Low levels of cell-free circulating miR-361-3p and miR-625* as blood-based markers for discriminating malignant from benign lung tumors. PLoS One. 2012; 7(6):e38248. PMC: 3366929. DOI: 10.1371/journal.pone.0038248. View

18.

Xu M, Wang Y . miR‑133a suppresses cell proliferation, migration and invasion in human lung cancer by targeting MMP‑14. Oncol Rep. 2013; 30(3):1398-404. DOI: 10.3892/or.2013.2548. View

19.

Simi L, Andreani M, Davini F, Janni A, Pazzagli M, Serio M . Simultaneous measurement of MMP9 and TIMP1 mRNA in human non small cell lung cancers by multiplex real time RT-PCR. Lung Cancer. 2004; 45(2):171-9. DOI: 10.1016/j.lungcan.2004.01.014. View

20.

Tsai C, Tsai H, Huang H, Hung C, Hsu C, Fong Y . Resistin promotes tumor metastasis by down-regulation of miR-519d through the AMPK/p38 signaling pathway in human chondrosarcoma cells. Oncotarget. 2014; 6(1):258-70. PMC: 4381593. DOI: 10.18632/oncotarget.2724. View